The fibroblast growth factors

The Cytokine Handbook

Volumn , Issue , 2003, Pages 747-781

  Ensoli, Barbara ^a   Sgadari, Cecilia ^a   Barillari, Giovanni ^a   Monini, Paolo ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 4744349093     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1016/B978-012689663-3/50035-1     Document Type: Chapter

References (323)

1. Abe K., Saito H. Neurotrophic effect of basic fibroblast growth factor is mediated by the p42/p44 mitogen-activated protein kinase cascade in cultured rat cortical neurons. Brain Res. Dev. Brain Res. 2000, 122:81-85.
2. Agarwala S., Kalil R.E. Long-term protection of axotomized neurons in the dorsal lateral geniculate nucleus in the rat following a single administration of basic fibroblast growth factor or ciliary neurotrophic factor. J. Comp Neurol. 1998, 392:264-272.
3. Ahmed N.U., Ueda M., Ito A., et al. Expression of fibroblast growth factor receptors in naevus-cell naevus and malignant melanoma. Melanoma Res. 1997, 7:299-305.
4. Allouche M. Basic fibroblast growth factor and hematopoiesis. Leukemia 1995, 9:937-942.
5. Amalric F., Bouche G., Bonnet H., et al. Fibroblast growth factor-2 (FGF-2) in the nucleus: translocation process and targets. Biochem. Pharmacol. 1994, 47:111-115.
6. Amaya E., Musci T.J., Kirschner M.W. Expression of a dominant negative mutant of the FGF receptor disrupts mesoderm formation in Xenopus embryos. Cell 1991, 66:257-270.
7. Amaya E., Stein P.A., Musci T.J., Kirschner M.W. FGF signaling in the early specification of mesoderm in Xenopus. Development 1993, 118:477-487.
8. Andersen K., Maelandsmo G.M., Hovig E., et al. Interleukin-1 alpha and basic fibroblast growth factor induction of matrix metalloproteinases and their inhibitors in osteosarcoma cells is modulated by the metastasis associated protein CAPL. Anticancer Res. 1998, 18:3299-3303.
9. Antoine M., Reimers K., Dickson C., Kiefer P. Fibroblast growth factor 3, a protein with dual subcellular localization, is targeted to the nucleus and nucleolus by the concerted action of two nuclear localization signals and a nucleolar retention signal. J. Biol. Chem. 1997, 272:29475-29481.
10. Aoyagi A., Nishikawa K., Saito H., Abe K. Characterization of basic fibroblast growth factor-mediated acceleration of axonal branching in cultured rat hippocampal neurons. Brain Res. 1994, 661:117-126.
11. Arese M., Chen Y., Florkiewicz R.Z., et al. Nuclear activities of basic fibroblast growth factor: potentiation of low-serum growth mediated by natural or chimeric nuclear localization signals. Mol. Biol. Cell 1999, 10:1429-1444.
12. Arman E., Haffner-Krausz R., Chen Y., et al. Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development. Proc. Natl Acad. Sci. USA 1998, 95:5082-5087.
13. Arnaud E., Touriol C., Boutonnet C., et al. A new 34-kilodalton isoform of human fibroblast growth factor 2 is cap dependently synthesized by using a non-AUG start codon and behaves as a survival factor. Mol. Cell Biol. 1999, 19:505-514.
14. Asahara T., Bauters C., Zheng L.P., et al. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 1995, 92:II365-II371.
15. Ascherl G., Sgadari C., Bugarini R., et al. Serum concentrations of fibroblast growth factor 2 are increased in HIV type 1-infected patients and inversely related to survival probability. AIDS Res. Hum. Retroviruses 2001, 17:1035-1039.
16. Aviezer D., Hecht D., Safran M., et al. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell 1994, 79:1005-1013.
17. Baird A., Esch F., Mormede P., et al. Molecular characterization of fibroblast growth factor: distribution and biological activities in various tissues. Recent Prog. Horm. Res. 1986, 42:143-205.
18. Baldin V., Roman A.M., Bosc-Bierne I., et al. Translocation of bFGF to the nucleus is G1 phase cell cycle specific in bovine aortic endothelial cells. EMBO J. 1990, 9:1511-1517.
19. Barillari G., Ensoli B. Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi’s sarcoma. Clin. Microbiol. Rev. 2002, 15:310-322.
20. Barillari G., Buonaguro L., Fiorelli V., et al. Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi’s sarcoma pathogenesis. J. Immunol. 1992, 149:3727-3734.
21. Barillari G., Gendelman R., Gallo R.C., Ensoli B. The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc. Natl. Acad. Sci. USA 1993, 90:7941-7945.
22. Barillari G., Sgadari C., Fiorelli V., et al. The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the alpha5betal and alphavbeta3 integrins and by mobilizing sequestered basic fibroblast growth factor. Blood 1999, 94:663-672.
23. Barillri G., Sgadari C., Palladino C., et al. Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi’s sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin. J. Immunol. 1999, 163:1929-1935.
24. Bellus G.A., Gaudenz K., Zackai E.H., et al. Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes. Nat. Genet. 1996, 14:174-176.
25. Bennett N.T., Schultz G.S. Growth factors and wound healing: Part II. Role in normal and chronic wound healing. Am. J. Surg. 1993, 166:74-81.
26. Berry D., Kwan C.P., Shriver Z., et al. Distinct heparan sulfate glycosaminoglycans are responsible for mediating fibroblast growth factor-2 biological activity through different fibroblast growth factor-2 biological activity through different fibroblast growth factor receptors. FASEB J. 2001, 15:1422-1424.
27. Besser D., Presta M., Nagamine Y. Elucidation of a signaling pathway induced by FGF-2 leading to uPA gene expression in NIH 3T3 fibroblasts. Cell Growth Differ. 1995, 6:1009-1017.
28. Bikfalvi A., Han Z.C., Fuhrmann G. Interaction of fibroblast growth factor (FGF) with megakaryocytopoiesis and demonstration of FGF receptor expression in megakaryocytes and megakaryocytic-like cells. Blood 1992, 80:1905-1913.
29. Bikfalvi A., Klein S., Pintucci G., Rifkin D.B. Biological roles of fibroblast growth factor-2. Endocr. Rev. 1997, 18:26-45.
30. Blotnick S., Peoples G.E., Freeman M.R., et al. T lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: differential production and release by CD4+ and CD8+ T cells. Proc. Natl. Acad. Sci. USA 1994, 91:2890-2894.
31. Boget S., Cereser C., Parvaz P., et al. Fibroblast growth factor receptor 1 (FGFR1) is over-expressed in benign prostatic hyperplasia whereas FGFR2-IIIc and FGFR3 are not. Eur. J. Endocrinol. 2001, 145:303-310.
32. Boilly B., Vercoutter-Edouart A.S., Hondermarck H., et al. FGF signals for cell proliferation and migration through different pathways. Cytokine Growth Factor Rev. 2000, 11:295-302.
33. Bonneh-Barkay D., Shlissel M., Berman B., et al. Identification of glypican as a dual modulator of the biological activity of fibroblast growth factors. J. Biol. Chem. 1997, 272:12415-12421.
34. Bouche G., Gas N., Prats H., et al. Basic fibroblast growth factor enters the nucleolus and stimulates the transcription of ribosomal genes in ABAE cells undergoing G0-G1 transition. Proc. Natl. Acad. Sci. USA 1987, 84:6770-6774.
35. Boulton M., Gregor Z., McLeod D., et al. Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management. Br. J. Ophthalmol. 1997, 81:228-233.
36. Brogi E., Winkles J.A., Underwood R., et al. Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. Association of acidic FGF with plaque microvessels and macrophages. J. Clin. Invest 1993, 92:2408-2418.
37. Brooks P.C., Clark R.A., Cheresh D.A. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 1994, 264:569-571.
38. Brooks P.C., Stromblad S., Sanders L.C., et al. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 1996, 85:683-693.
39. Brunner G., Nguyen H., Gabrilove J., et al. Basic fibroblast growth factor expression in human bone marrow and peripheral blood cells. Blood 1993, 81:631-638.
40. Burke C.J., Volkin D.B., Mach H., Middaugh C.R. Effect of polyanions on the unfolding of acidic fibroblast growth factor. Biochemistry 1993, 32:6419-6426.
41. Burrus L.W., Zuber M.E., Lueddecke B.A., Olwin B.B. Identification of a cysteine-rich receptor for fibroblast growth factors. Mol. Cell Biol. 1992, 12:5600-5609.
42. Calara F., Ameli S., Hultgardh-Nilsson A., et al. Autocrine induction of DNA synthesis by mechanical injury of cultured smooth muscle cells. Potential role of FGF and PDGF. Arterioscler. Thromb. Vasc. Biol. 1996, 16:187-193.
43. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature 2000, 407:249-257.
44. Carreira C.M., LaVallee T.M., Tarantini F., et al. S100A13 is involved in the regulation of fibroblast growth factor-1 and p40 synaptotagmin-1 release in vitro. J. Biol. Chem. 1998, 273:22224-22231.
45. Casscells W., Speir E., Sasse J., et al. Isolation, characterization, and localization of heparin-binding growth factors in the heart. J. Clin. Invest 1990, 85:433-441.
46. Chai N., Patel Y., Jacobson K., et al. FGF is an essential regulator of the fifth cell division in preimplantation mouse embryos. Dev. Biol. 1998, 198:105-115.
47. Chang E., Boyd A., Nelson C.C., et al. Successful treatment of infantile hemangiomas with interferonalpha-2b. J. Pediatr. Hematol. Oncol. 1997, 19:237-244.
48. Chang H.C., Samaniego F., Nair B.C., et al. HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. AIDS 1997, 11:1421-1431.
49. Cheng G.C., Briggs W.H., Gerson D.S., et al. Mechanical strain tightly controls fibroblast growth factor-2 release from cultured human vascular smooth muscle cells. Circ. Res. 1997, 80:28-36.
50. Chesi M., Brents L.A., Ely S.A., et al. Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma. Blood 2001, 97:729-736.
51. Choi K., Kennedy M., Kazarov A., et al. A common precursor for hematopoietic and endothelial cells. Development 1998, 125:725-732.
52. Clarke M.S., Feeback D.L. Mechanical load induces sarcoplasmic wounding and FGF release in differentiated human skeletal muscle cultures. FASEB J. 1996, 10:502-509.
53. Clarke W.E., Berry M., Smith C., et al. Coordination of fibroblast growth factor receptor 1 (FGFR1) and fibroblast growth factor-2 (FGF-2) trafficking to nuclei of reactive astrocytes around cerebral lesions in adult rats. Mol. Cell Neurosci. 2001, 17:17-30.
54. Clasper S., Vekemans S., Fiore M., et al. Inducible expression of the cell surface heparan sulfate proteoglycan syndecan-2 (fibroglycan) on human activated macrophages can regulate fibroblast growth factor action. J. Biol. Chem. 1999, 274:24113-24123.
55. Cohen M.M. Short-limb skeletal dysplasias and craniosynostosis: what do they have in common?. Pediatr. Radiol. 1997, 27:442-446.
56. Cohn M.J., Izpisua-Belmonte J.C., Abud H., et al. Fibroblast growth factors induce additional limb development from the flank of chick embryos. Cell 1995, 80:739-746.
57. Cordon-Cardo C., Vlodavsky I., Haimovitz-Friedman A., et al. Expression of basic fibroblast growth factor in normal human tissues. Lab Invest 1990, 63:832-840.
58. Costa M., Danesi R., Agen C., et al. MCF-10A cells infected with the int-2 oncogene induce angiogenesis in the chick chorioallantoic membrane and in the rat mesentery. Cancer Res. 1994, 54:9-11.
59. Coulier F., Pontarotti P., Roubin R., et al. Of worms and men: an evolutionary perspective on the fibroblast growth factor (FGF) and FGF receptor families. J. Mol. Evol. 1997, 44:43-56.
60. Crabb J.W., Armes L.G., Carr S.A., et al. Complete primary structure of prostatropin, a prostate epithelial cell growth factor. Biochemistry 1986, 25:4988-4993.
61. Cross M.J., Hodgkin M.N., Roberts S., et al. Tyrosine 766 in the fibroblast growth factor receptor-1 is required for FGF-stimulation of phospholipase C, phospholipase D, phospholipase A(2), phosphoinositide 3-kinase and cytoskeletal reorganisation in porcine aortic endothelial cells. J. Cell Sci. 2000, 113:643-651.
62. Crossley P.H., Martinez S., Martin G.R. Midbrain development induced by FGF8 in the chick embryo. Nature 1996, 380:66-68.
63. Czubayko F., Liaudet-Coopman E.D., Aigner A., et al. A secreted FGF-binding protein can serve as the angiogenic switch in human cancer. Nat. Med. 1997, 3:1137-1140.
64. D’Amato R.J., Loughnan M.S., Flynn E., Folkman J. Thalidomide is an inhibitor of angiogenesis. Proc. Natl Acad Sci. USA 1994, 91:4082-4085.
65. Dahl J.P., Binda A., Canfield V.A., Levenson R. Participation of Na, K-ATPase in FGF-2 secretion: rescue of ouabain-inhibitable FGF-2 secretion by ouabain-resistant Na, K-ATPase alpha subunits. Biochemistry 2000, 39:14877-14883.
66. Datta S.R., Brunet A., Greenberg M.E. Cellular survival: a play in three Akts. Genes Dev. 1999, 13:2905-2927.
67. Davis M.G., Zhou M., Ali S., et al. Intracrine and autocrine effects of basic fibroblast growth factor in vascular smooth muscle cells. J. Mol. Cell Cardiol. 1997, 29:1061-1072.
68. Delrieu I. The high molecular weight isoforms of basic fibroblast growth factor (FGF-2): an insight into an intracrine mechanism. FEBS Lett. 2000, 468:6-10.
69. Demiroglu A., Steer E.J., Heath C., et al. The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins. Blood 2001, 98:3778-3783.
70. Deng C.X., Wynshaw-Boris A., Shen M.M., et al. Murine FGFR-1 is required for early postimplantation growth and axial organization. Genes Dev. 1994, 8:3045-3057.
71. Di Blasio A.M., Carniti C., Vigano P., et al. Basic fibroblast growth factor messenger ribonucleic acid levels in human placentas from normal and pathological pregnancies. Mol. Hum. Reprod. 1997, 3:1119-1123.
72. Dickson C., Spencer-Dene B., Dillon C., Fantl V. Tyrosine kinase signalling in breast cancer: fibroblast growth factors and their receptors. Breast Cancer Res. 2000, 2:191-196.
73. DiGabriele A.D., Lax I., Chen D.I., et al. Structure of a heparin-linked biologically active dimer of fibroblast growth factor. Nature 1998, 393:812-817.
74. DiMario J., Buffinger N., Yamada S., Strohman R.C. Fibroblast growth factor in the extracellular matrix of dystrophic (mdx) mouse muscle. Science 1989, 244:688-690.
75. Dimitroff C.J., Klohs W., Sharma A., et al. Antiangiogenic activity of selected receptor tyrosine kinase inhibitors, PD166285 and PD173074: implications for combination treatment with photodynamic therapy. Invest New Drugs 1999, 17:121-135.
76. Dinney C.P., Bielenberg D.R., Perrotte P., et al. Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration. Cancer Res. 1998, 58:808-814.
77. Dono R., Zeller R. Cell-type-specific nuclear translocation of fibroblast growth factor-2 isoforms during chicken kidney and limb morphogenesis. Dev. Biol. 1994, 163:316-330.
78. Dono R., Texido G., Dussel R., et al. Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice. EMBO J. 1998, 17:4213-4225.
79. Eliceiri B.P., Klemke R., Stromblad S., Cheresh D.A. Integrin alphavbeta3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis. J. Cell Biol. 1998, 140:1255-1263.
80. Ensoli B., Nakamura S., Salahuddin S.Z., et al. AIDS-Kaposi’s sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science 1989, 243:223-226.
81. Ensoli B., Barillari G., Salahuddin S.Z., et al. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi’s sarcoma lesions of AIDS patients. Nature 1990, 345:84-86.
82. Ensoli B., Buonaguro L., Barillari G., et al. Release, uptake, and effects of extracellular human immuno-deficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 1993, 67:277-287.
83. Ensoli B., Gendelman R., Markham P., et al. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi’s sarcoma. Nature 1994, 371:674-680.
84. Ensoli B., Markham P., Kao V., et al. Block of AIDS-Kaposi’s sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS. J. Clin. Invest 1994, 94:1736-1746.
85. Ensoli B., Sturzl M., Monini P. Reactivation and role of HHV-8 in Kaposi’s sarcoma initiation. Adv. Cancer Res. 2001, 81:161-200.
86. Esch F., Baird A., Ling N., et al. Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. Proc. Natl Acad. Sci. USA 1985, 82:6507-6511.
87. Ezzat S., Zheng L., Zhu X.F., et al. Targeted expression of a human pituitary tumor-derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesis. J. Clin. Invest 2002, 109:69-78.
88. Faham S., Linhardt R.J., Rees D.C. Diversity does make a difference: fibroblast growth factor-heparin interactions. Curr. Opin. Struct. Biol. 1998, 8:578-586.
89. Fallon J.F., Lopez A., Ros M.A., et al. FGF-2: apical ectodermal ridge growth signal for chick limb development. Science 1994, 264:104-107.
90. Fanales-Belasio E., Moretti S., Nappi F., et al. Native HIV-1 Tat protein targets monocyte-derived dendritic cells and enhances their maturation, function, and antigen-specific T cell responses. J. Immunol. 2002, 168:197-206.
91. Fannon M., Nugent M.A. Basic fibroblast growth factor binds its receptors is internalized, and stimulates DNA synthesis in Balb/c3T3 cells in the absence of heparan sulfate. J. Biol. Chem. 1996, 271:17949-17956.
92. Fannon M., Forsten K.E., Nugent M.A. Potentiation and inhibition of bFGF binding by heparin: a model for regulation of cellular response. Biochemistry 2000, 39:1434-1445.
93. Faris M., Ensoli B., Stahl N., et al. Differential activation of the extracellular signal-regulated kinase, Jun kinase and Janus kinase-Stat pathways by oncostatin M and basic fibroblast growth factor in AIDS-derived Kaposi’s sarcoma cells. AIDS 1996, 10:369-378.
94. Faris M., Ensoli B., Kokot N., Nel A.E. Inflammatory cytokines induce the expression of basic fibroblast growth factor (bFGF) isoforms required for the growth of Kaposi’s sarcoma and endothelial cells through the activation of AP-1 response elements in the bFGF promoter. AIDS 1998, 12:19-27.
95. Fedarko N.S., Conrad H.E. A unique heparan sulfate in the nuclei of hepatocytes: structural changes with the growth state of the cells. J. Cell Biol. 1986, 102:587-599.
96. Fiore M.M. Cellular specificity for the activation of fibroblast growth factor-2 by heparan sulfate proteoglycan. Biochem. Biophys. Res. Commun. 2001, 284:384-388.
97. Fiorelli V., Gendelman R., Samaniego F., et al. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi’s sarcoma spindle cells. J. Clin. Invest 1995, 95:1723-1734.
98. Fiorelli V., Gendelman R., Sirianni M.C., et al. Gamma-Interferon produced by CD8+T cells infiltrating Kaposi’s sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: an immune response to human herpesvirus-8 infection?. Blood 1998, 91:956-967.
99. Flamme I., Frolich T., Risau W. Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J. Cell Physiol 1997, 173:206-210.
100. Florkiewicz R.Z., Sommer A. Human basic fibroblast growth factor gene encodes four polypeptides: three initiate translation from non-AUG codons. Proc. Natl Acad. Sci. USA 1989, 86:3978-3981.
101. Florkiewicz R.Z., Anchin J., Baird A. The inhibition of fibroblast growth factor-2 export by cardenolides implies a novel function for the catalytic subunit of Na+, K+-ATPase. J. Biol. Chem. 1998, 273:544-551.
102. Folkman J., Klagsbrun M. Angiogenic factors. Science 1987, 235:442-447.
103. Folkman J., Shing Y. Angiogenesis. J. Biol. Chem. 1992, 267:10931-10934.
104. Folkman J., Watson K., Ingber D., Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989, 339:58-61.
105. Fonesca R., Oken M.M., Greipp P.R. The t(4;14) (p16.3;q32) is strongly associated with chromosome 13 abnormalities in both multiple myeloma and monoclonal gammopathy of undetermined significance. Blood 2001, 98:1271-1272.
106. Ford-Perriss M., Abud H., Murphy M. Fibroblast growth factors in the developing central nervous system. Clin. Exp. Pharmacol. Physiol. 2001, 28:493-503.
107. Frank R.N., Amin R.H., Eliott D., et al. Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes. Am. J. Ophthalmol. 1996, 122:393-403.
108. Friedlander M., Brooks P.C., Shaffer R.W., et al. Definition of two angiogenic pathways by distinct alpha v integrins. Science 1995, 270:1500-1502.
109. Gabbianelli M., Sargiacomo M., Pelosi E., et al. ’Pure’ human hematopoietic progenitors: permissive action of basic fibroblast growth factor. Science 1990, 249:1561-1564.
110. Gabrilove J.L., Wong G., Bollenbacher E., et al. Basic fibroblast growth factor counteracts the suppressive effect of transforming growth factor-beta 1 on human myeloid progenitor cells. Blood 1993, 81:909-915.
111. Gabrilove J.L., White K., Rahman Z., Wilson E.L. Stem cell factor and basic fibroblast growth factor are synergistic in augmenting committed myeloid progenitor cell growth. Blood 1994, 83:907-910.
112. Gallicchio V.S., Hughes N.K., Hulette B.C., et al. Basic fibroblast growth factor (B-FGF) induces early-(CFU-s) and late-stage hematopoietic progenitor cell colony formation (CFU-gm, CFU-meg, and BFU-e) by synergizing with GM-CSF, Meg-CSF, and erythropoietin, and is a radioprotective agent in vitro. Int. J. Cell Cloning 1991, 9:220-232.
113. Gannoun-Zaki L., Pieri I., Badet J., et al. Internalization of basic fibroblast growth factor by Chinese hamster lung fibroblast cells: involvement of several pathways. Exp. Cell Res. 1991, 197:272-279.
114. Gaubert F., Escaffit F., Bertrand C., et al. Expression of the high molecular weight fibroblast growth factor-2 isoform of 210 amino acids is associated with modulation of protein kinases C delta and epsilon and ERK activation. J. Biol. Chem. 2001, 276:1545-1554.
115. Gautschi-Sova P., Jiang Z.P., Frater-Schroder M., Bohlen P. Acidic fibroblast growth factor is present in nonneural tissue: isolation and chemical characterization from bovine kidney. Biochemistry 1987, 26:5844-5847.
116. Gillis P., Savla U., Volpert O.V., et al. Keratinocyte growth factor induces angiogenesis and protects endothelial barrier function. J. Cell Sci. 1999, 112:2049-2057.
117. Giri D., Ropiquet F., Ittmann M. Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer. Clin. Cancer Res. 1999, 5:1063-1071.
118. Givol D., Yayon A. Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. FASEB J. 1992, 6:3362-3369.
119. Gonatas J.O., Mourelatos Z., Stieber A., et al. MG-160, a membrane sialoglycoprotein of the medial cisternae of the rat Golgi apparatus, binds basic fibroblast growth factor and exhibits a high level of sequence identity to a chicken fibroblast growth factor receptor. J. Cell Sci. 1995, 108:457-467.
120. Goretzki L., Burg M.A., Grako K.A., Stallcup W.B. High-affinity binding of basic fibroblast growth factor and platelet-derived growth factor-AA to the core protein of the NG2 proteoglycan. J. Biol. Chem. 1999, 274:16831-16837.
121. Gosgnach W., Challah M., Coulet F., et al. Shear stress induces angiotensin converting enzyme expression in cultured smooth muscle cells: possible involvement of bFGF. Cardiovasc. Res. 2000, 45:486-492.
122. Gospodarowicz D., Ferrara N., Haaparanta T., Neufeld G. Basic fibroblast growth factor: expression in cultured bovine vascular smooth muscle cells. Eur. J. Cell Biol. 1988, 46:144-151.
123. Grothe C., Nikkhah G. The role of basic fibroblast growth factor in peripheral nerve regeneration. Anat. Embryol. (Berl) 2001, 204:171-177.
124. Guenzi E., Topolt K., Cornali E., et al. The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines. EMBO J. 2001, 20:5568-5577.
125. Hadari Y.R., Gotoh N., Kouhara H., et al. Critical role for the docking-protein FRS2 alpha in FGF receptor-mediated signal transduction pathways. Proc. Natl Acad. Sci. USA 2001, 98:8578-8583.
126. Hammes H.P., Brownlee M., Jonczyk A., et al. Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nat. Med. 1996, 2:529-533.
127. Hanneken A., Lutty G.A., McLeod D.S., et al. Localization of basic fibroblast growth factor to the developing capillaries of the bovine retina. J. Cell Physiol. 1989, 138:115-120.
128. Hatai M., Hashi H., Mogi A., et al. Stimulation of tyrosine- and serine-phosphorylation of focal adhesion kinase in mouse 3T3 cells by fibronectin and fibroblast growth factor. FEBS Lett. 1994, 350:113-116.
129. Hatten M.E., Lynch M., Rydel R.E., et al. In vitro neurite extension by granule neurons is dependent upon astroglial-derived fibroblast growth factor. Dev. Biol. 1988, 125:280-289.
130. Herr A.B., Ornitz D.M., Sasisekharan R., et al. Heparin-induced self-association of fibroblast growth factor-2. Evidence for two oligomerization processes. J. Biol. Chem. 1997, 272:16382-16389.
131. Hirschi K.K., D’Amore P.A. Control of angiogenesis by the pericyte: molecular mechanisms and significance. EXS 1997, 79:419-428.
132. Hu G., Kim H., Xu C., Riordan J.F. Fibroblast growth factors are translocated to the nucleus of human endothelial cells in a microtubule- and lysosome-independent pathway. Biochem. Biophys. Res. Commun. 2000, 273:551-556.
133. Hughes S.E., Crossman D., Hall P.A. Expression of basic and acidic fibroblast growth factors and their receptor in normal and atherosclerotic human arteries. Cardiovasc. Res. 1993, 27:1214-1219.
134. Hulett M.D., Freeman C., Hamdorf B.J., et al. Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat. Med. 1999, 5:803-809.
135. Imamura T., Oka S., Tanahashi T., Okita Y. Cell cycle-dependent nuclear localization of exogenously added fibroblast growth factor-1 in BALB/c 3T3 and human vascular endothelial cells. Exp. Cell Res. 1994, 215:363-372.
136. Ingber D.E., Folkman J. Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix. J. Cell Biol. 1989, 109:317-330.
137. Iozzo R.V. Matrix proteoglycans: from molecular design to cellular function. Annu. Rev. Biochem. 1998, 67:609-652.
138. Iozzo R.V., San Antonio J.D. Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena. J. Clin. Invest 2001, 108:349-355.
139. Ishibashi H., Shiratuchi T., Nakagawa K., et al. Hypoxia-induced angiogenesis of cultured human salivary gland carcinoma cells enhances vascular endothelial growth factor production and basic fibroblast growth factor release. Oral Oncol. 2001, 37:77-83.
140. Ito A., Sato T., Iga T., Mori Y. Tumor necrosis factor bifunctionally regulates matrix metalloproteinases and tissue inhibitor of metalloproteinases (TIMP) production by human fibroblasts. FEBS Lett. 1990, 269:93-95.
141. Jackson A., Friedman S., Zhan X., et al. Heat shock induces the release of fibroblast growth factor 1 from NIH 3T3 cells. Proc. Natl. Acad. Sci. USA 1992, 89:10691-10695.
142. Jackson A., Tarantini F., Gamble S., et al. The release of fibroblast growth factor-1 from NIH 3T3 cells in response to temperature involves the function of cysteine residues. J. Biol. Chem. 1995, 270:33-36.
143. Jans D.A., Hassan G. Nuclear targeting by growth factors, cytokines, and their receptors: a role in signaling?. Bioessays 1998, 20:400-411.
144. Johnston C.L., Cox H.C., Gomm J.J., Coombes R.C. Fibroblast growth factor receptors (FGFRs) localize in different cellular compartments. A splice variant of FGFR-3 localizes to the nucleus. J. Biol. Chem. 1995, 270:30643-30650.
145. Jones M., Tussey L., Athanasou N., Jackson D.G. Heparan sulfate proteoglycan isoforms of the CD44 hyaluronan receptor induced in human inflammatory macrophages can function as paracrine regulators of fibroblast growth factor action. J. Biol. Chem. 2000, 275:7964-7974.
146. Joy A., Moffett J., Neary K., et al. Nuclear accumulation of FGF-2 is associated with proliferation of human astrocytes and glioma cells. Oncogene 1997, 14:171-183.
147. Kan M., Wang F., Xu J., et al. An essential heparin-binding domain in the fibroblast growth factor receptor kinase. Science 1993, 259:1918-1921.
148. Kan M., Wang F., To B., et al. Divalent cations and heparin/heparan sulfate cooperate to control assembly and activity of the fibroblast growth factor receptor complex. J. Biol. Chem. 1996, 271:26143-26148.
149. Kanda S., Tomasini-Johansson B., Klint P., et al. Signaling via fibroblast growth factor receptor-1 is dependent on extracellular matrix in capillary endothelial cell differentiation. Exp. Cell Res. 1999, 248:203-213.
150. Kannan K., Givol D. FGF receptor mutations: dimerization syndromes, cell growth suppression, and animal models. IUBMB. Life 2000, 49:197-205.
151. Karsan A., Yee E., Poirier G.G., et al. Fibroblast growth factor-2 inhibits endothelial cell apoptosis by Bcl-2-dependent and independent mechanisms. Am. J. Pathol. 1997, 151:1775-1784.
152. Keresztes M., Boonstra J. Import(ance) of growth factors in(to) the nucleus. J. Cell Biol. 1999, 145:421-424.
153. Kiefer P., Acland P., Pappin D., et al. Competition between nuclear localization and secretory signals determines the subcellular fate of a single CUG-initiated form of FGF3. EMBO J. 1994, 13:4126-4136.
154. Kiefer P., Dickson C. Nucleolar association of fibroblast growth factor 3 via specific sequence motifs has inhibitory effects on cell growth. Mol. Cell Biol. 1995, 15:4364-4374.
155. Kilkenny D.M., Hill D.J. Perinuclear localization of an intracellular binding protein related to the fibroblast growth factor (FGF) receptor 1 is temporally associated with the nuclear trafficking of FGF-2 in proliferating epiphyseal growth plate chondrocytes. Endocrinology 1996, 137:5078-5089.
156. Kim I., Moon S., Yu K., et al. A novel fibroblast growth factor receptor-5 preferentially expressed in the pancreas. Biochim. Biophys. Acta 2001, 1518:152-156.
157. Klein S., Roghani M., Rifkin D.B. Fibroblast growth factors as angiogenesis factors: new insights into their mechanism of action. Regulation of Angiogenesis 1997, 159-192. Birkhauser, Boston. I.D. Goldberg, E.M. Rosen (Eds.).
158. Klint P., Claesson-Welsh L. Signal transduction by fibroblast growth factor receptors. Front Biosci. 1999, 4:D165-D177.
159. Klint P., Kanda S., Kloog Y., Claesson-Welsh L. Contribution of Src and Ras pathways in FGF-2 induced endothelial cell differentiation. Oncogene 1999, 18:3354-3364.
160. Knox S., Merry C., Stringer S., et al. Not all perlecans are created equal: interactions with fibroblast growth factor 2 (FGF-2) and FGF receptors. J. Biol. Chem. 2002, 277:14657-14665.
161. Kohl R., Antoine M., Olwin B.B., et al. Cysteine-rich fibroblast growth factor receptor alters secretion and intracellular routing of fibroblast growth factor 3. J. Biol. Chem. 2000, 275:15741-15748.
162. Konig A., Menzel T., Lynen S., et al. Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis. Leukemia 1997, 11:258-265.
163. Korah R.M., Sysounthone V., Golowa Y., Wieder R. Basic fibroblast growth factor confers a less malignant phenotype in MDA-MB-231 human breast cancer cells. Cancer Res. 2000, 60:733-740.
164. Koritschoner N.P., Bartunek P., Knespel S., et al. The fibroblast growth factor receptor FGFR-4 acts as a ligand dependent modulator of erythroid cell proliferation. Oncogene 1999, 18:5904-5914.
165. Koritschoner N.P., Bartunek P., Knespel S., et al. The fibroblast growth factor receptor FGFR-4 acts as a ligand dependent modulator of erythroid cell proliferation. Oncogene 1999, 18:5904-5914.
166. Kornmann M., Ishiwata T., Beger H.G., Korc M. Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: evidence for autocrine and paracrine actions. Oncogene 1997, 15:1417-1424.
167. Kouhara H., Hadari Y.R., Spivak-Kroizman T., et al. A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway. Cell 1997, 89:693-702.
168. Krah K., Mironov V., Risau W., Flamme I. Induction of vasculogenesis in quail blastodisc-derived embryoid bodies. Dev. Biol. 1994, 164:123-132.
169. Kurtz A., Wang H.L., Darwiche N., et al. Expression of a binding protein for FGF is associated with epithelial development and skin carcinogenesis. Oncogene 1997, 14:2671-2681.
170. Kusakabe M., Masuyama N., Hanafusa H., Nishida E. Xenopus FRS2 is involved in early embryogenesis in cooperation with the Src family kinase Laloo. EMBO Rep. 2001, 2:727-735.
171. LaVallee T.M., Prudovsky I.A., McMahon G.A., et al. Activation of the MAP kinase pathway by FGF-1 correlates with cell proliferation induction while activation of the Src pathway correlates with migration. J. Cell Biol. 1998, 141:1647-1658.
172. LaVallee T.M., Tarantini F., Gamble S., et al. Synaptotagmin-1 is required for fibroblast growth factor-1 release. J. Biol. Chem. 1998, 273:22217-22223.
173. Le Y.J., Corry P.M. Hypoxia-induced bFGF gene expression is mediated through the JNK signal transduction pathway. Mol. Cell Biochem. 1999, 202:1-8.
174. Liang Y., Haring M., Roughley P.J., et al. Glypican and biglycan in the nuclei of neurons and glioma cells: presence of functional nuclear localization signals and dynamic changes in glypican during the cell cycle. J. Cell Biol. 1997, 139:851-864.
175. Liu D., Shriver Z., Venkataraman G., et al. Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasis. Proc. Natl Acad. Sci. USA 2002, 99:568-573.
176. Lobb R.R. Thrombin inactivates acidic fibroblast growth factor but not basic fibroblast growth factor. Biochemistry 1988, 27:2572-2578.
177. Loo B.M., Kreuger J., Jalkanen M., et al. Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4. J. Biol. Chem. 2001, 276:16868-16876.
178. Maciag T., Mehlman T., Friesel R., Schreiber A.B. Heparin binds endothelial cell growth factor, the principal endothelial cell mitogen in bovine brain. Science 1984, 225:932-935.
179. Maher P.A. Nuclear translocation of fibroblast growth factor (FGF) receptors in response to FGF-2. J. Cell Biol. 1996, 134:529-536.
180. Malek A.M., Gibbons G.H., Dzau V.J., Izumo S. Fluid shear stress differentially modulates expression of genes encoding basic fibroblast growth factor and platelet-derived growth factor B chain in vascular endothelium. J. Clin. Invest 1993, 92:2013-2021.
181. Manabe N., Oda H., Nakamura K., et al. Involvement of fibroblast growth factor-2 in joint destruction of rheumatoid arthritis patients. Rheumatology (Oxford) 1999, 38:714-720.
182. Martin G.R. The roles of FGFs in the early development of vertebrate limbs. Genes Dev. 1998, 12:1571-1586.
183. Mathieu M., Chatelain E., Ornitz D., et al. Receptor binding and mitogenic properties of mouse fibroblast growth factor 3. Modulation of response by heparin. J. Biol. Chem. 1995, 270:24197-24203.
184. Mattson M.P., Tomaselli K.J., Rydel R.E. Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF. Brain Res. 1993, 621:35-49.
185. McNeil P.L., Muthukrishnan L., Warder E., D’Amore P.A. Growth factors are released by mechanically wounded endothelial cells. J. Cell Biol. 1989, 109:811-822.
186. Mellin T.N., Cashen D.E., Ronan J.J., et al. Acidic fibroblast growth factor accelerates dermal wound healing in diabetic mice. J. Invest Dermatol. 1995, 104:850-855.
187. Meyers E.N., Lewandoski M., Martin G.R. An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination. Nat. Genet. 1998, 18:136-141.
188. Miao H.Q., Ornitz D.M., Aingorn E., et al. Modulation of fibroblast growth facotr-2 receptor binding, dimerization, signaling, and angiogenic activity by a synthetic heparin-mimicking polyanionic compound. J. Clin. Invest. 1997, 99:1565-1575.
189. Mignatti P., Mazzieri R., Rifkin D.B. Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor. J. Cell Biol. 1991, 113:1193-1201.
190. Mignatti P., Morimoto T., Rifkin D.B. Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J. Cell Physiol. 1992, 151:81-93.
191. Mihalcea A.M., Smith D.L., Monini P., et al. Treatment update for AIDS-related Kaposi’s sarcoma. AIDS 1999, 13(Suppl A):S215-S225.
192. Milev P., Monnerie H., Popp S., et al. The core protein of the chondroitin sulfate proteoglycan phosphacan is a high-affinity ligand of fibroblast growth factor-2 and potentiates its mitogenic activity. J. Biol. Chem. 1998, 273:21439-21442.
193. Miller D.L., Ortega S., Bashayan O., et al. Compensation by fibroblast growth factor 1 (FGF1) does not account for the mild phenotypic defects observed in FGF2 null mice. Mol. Cell Biol. 2000, 20:2260-2268.
194. Miyakawa K., Hatsuzawa K., Kurokawa T., et al. A hydrophobic region locating at the center of fibroblast growth factor-9 is crucial for its secretion. J. Biol. Chem. 1999, 274:29352-29357.
195. Miyake A., Konishi M., Martin F.H., et al. Structure and expression of a novel member, FGF-16, on the fibroblast growth factor family. Biochem. Biophys. Res. Commun. 1998, 243:148-152.
196. Miyamoto S., Teramoto H., Gutkind J.S., Yamada K.M. Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors. J. Cell Biol. 1996, 135:1633-1642.
197. Mohammadi M., McMahon G., Sun L., et al. Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors. Science 1997, 276:955-960.
198. Mohammadi M., Schlessinger J., Hubbard S.R. Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism. Cell 1996, 86:577-587.
199. Mohammadi M., Froum S., Hamby J.M., et al. Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain. EMBO J. 1998, 17:5896-5904.
200. Mongiat M., Taylor K., Otto J., et al. The protein core of the proteoglycan perlecan binds specifically to fibroblast growth factor-7. J. Biol. Chem. 2000, 275:7095-7100.
201. Montesano R., Vassalli J.D., Baird A., et al. Basic fibroblast growth factor induces angiogenesis in vitro. Proc. Natl Acad. Sci. USA 1986, 83:7297-7301.
202. Moon A.M., Capecchi M.R. Fgf8 is required for outgrowth and patterning of the limbs. Nat. Genet. 2000, 26:455-459.
203. Morris C.B., Gendelman R., Marrogi A.J., et al. Immunohistochemical detection of Bcl-2 in AIDS-associated and classical Kaposi’s sarcoma. Am. J. Pathol. 1996, 148:1055-1063.
204. Morrison R.S., Sharma A., de Vellis J., Bradshaw R.A. Basic fibroblast growth factor supports the survival of cerebral cortical neurons in primary culture. Proc. Natl Acad. Sci. USA 1986, 83:7537-7541.
205. Moy F.J., Safran M., Seddon A.P., et al. Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor. Biochemistry 1997, 36:4782-4791.
206. Munoz-Sanjuan I., Smallwood P.M., Nathans J. Isoform diversity among fibroblast growth factor homologous factors is generated by alternative promoter usage and differential splicing. J. Biol. Chem. 2000, 275:2589-2597.
207. Munoz-Sanjuan I., Cooper M.K., Beachy P.A., et al. Expression and regulation of chicken fibroblast growth factor homologous factor (FHF)-4 during craniofacial morphogenesis. Dev. Dyn. 2001, 220:238-245.
208. Murai N., Ueba T., Takahashi J.A., et al. Apoptosis of human glioma cells in vitro and in vivo induced by a neutralizing antibody against human basic fibroblast growth factor. J. Neurosurg. 1996, 85:1072-1077.
209. Murono E.P., Washburn A.L., Goforth D.P., Wu N. Evidence that both receptor- and heparan sulfate proteoglycan-bound basic fibroblast growth factor are internalized by cultured immature Leydig cells. Mol. Cell Endocrinol. 1993, 98:81-90.
210. Nagase H., Woessner J.F. Matrix metalloproteinases. J. Biol. Chem. 1999, 274:21491-21494.
211. Nanus D.M., Schmitz-Drager B.J., Motzer R.J., et al. Expression of basic fibroblast growth factor in primary human renal tumors: correlation with poor survival. J. Natl Cancer Inst. 1993, 85:1597-1599.
212. Naruo K., Seko C., Kuroshima K., et al. Novel secretory heparin-binding factors from human glioma cells (glia-activating factors) involved in glial cell growth. Purification and biological properties. J. Biol. Chem. 1993, 268:2857-2864.
213. Naski M.C., Ornitz D.M. FGF signaling in skeletal development. Front. Biosci. 1998, 3:D781-D794.
214. Neely K.A., Gardner T.W. Ocular neovascularization: clarifying complex interactions. Am. J. Pathol. 1998, 153:665-670.
215. Nguyen M., Watanabe H., Budson A.E., et al. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J. Natl Cancer Inst. 1994, 86:356-361.
216. Niswander L., Tickle C., Vogel A., et al. FGF-4 replaces the apical ectodermal ridge and directs out-growth and patterning of the limb. Cell 1993, 75:579-587.
217. Nugent M.A., Iozzo R.V. Fibroblast growth factor-2. Int. J. Biochem. Cell Biol. 2000, 32:115-120.
218. Ohmachi S., Watanabe Y., Mikami T., et al. FGF-20, a novel neurotrophic factor, preferentially expressed in the substantia nigra pars compacta of rat brain. Biochem. Biophys. Res. Commun. 2000, 277:355-360.
219. Okumura M., Okuda T., Nakamura T., Yajima M. Acceleration of wound healing in diabetic mice by basic fibroblast growth factor. Biol. Pharm. Bull. 1996, 19:530-535.
220. Oliver L.J., Rifkin D.B., Gabrilove J., et al. Long-term culture of human bone marrow stromal cells in the presence of basic fibroblast growth factor. Growth Factors 1990, 3:231-236.
221. Ong S.H., Guy G.R., Hadari Y.R., et al. FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors. Mol. Cell Biol. 2000, 20:979-989.
222. Ong S.H., Hadari Y.R., Gotoh N., et al. Stimulation of phosphatidylinositol 3-kinase by fibroblast growth factor receptors is mediated by coordinated recruitment of multiple docking proteins. Proc. Natl Acad. Sci. USA 2001, 98:6074-6079.
223. Ornitz D.M. FGFs, heparan sulfate and FGFRs: complex interactions essential for development. Bioessays 2000, 22:108-112.
224. Ornitz D.M., Itoh N. Fibroblast growth factors. Genome Biol. 2001, 2. REVIEWS3005.
225. Ortega S., Ittmann M., Tsang S.H., et al. Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc. Natl Acad. Sci. USA 1998, 95:5672-5677.
226. Otto D., Frotscher M., Unsicker K. Basic fibroblast growth factor and nerve growth factor administered in gel foam rescue medial septal neurons after fimbria fornix transection. J. Neurosci. Res. 1989, 22:83-91.
227. Padera R., Venkataraman G., Berry D., et al. FGF-2/fibroblast growthfactor receptor/heparin-like glycosaminoglycan interactions: a compensation model for FGF-2 signaling. FASEB J. 1999, 13:1677-1687.
228. Panek R.L., Lu G.H., Dahring T.K., et al. In vitro biological characterization and antiangiogenic effects of PD 166866, a selective inhibitor of the FGF-1 receptor tyrosine kinase. J. Pharmacol. Exp. Ther. 1998, 286:569-577.
229. Paterno G.D., Gillespie L.L., Dixon M.S., et al. Mesoderm-inducing properties of INT-2 and kFGF: two oncogene-encoded growth factors related to FGF. Development 1989, 106:79-83.
230. Peitz M., Pfannkuche K., Rajewsky K., Edenhofer F. Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic engineering of mammalian genomes. Proc. Natl Acad. Sci. USA 2002, 99:4489-4494.
231. Pilcher B.K., Dumin J., Schwartz M.J., et al. Keratinocyte collagenase-1 expression requires an epidermal growth factor receptor autocrine mechanism. J. Biol. Chem. 1999, 274:10372-10381.
232. Plotnikov A.N., Schlessinger J., Hubbard S.R., Mohammadi M. Structural basis for FGF receptor dimerization and activation. Cell 1999, 98:641-650.
233. Plotnikov A.N., Hubbard S.R., Schlessinger J., Mohammadi M. Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity. Cell 2000, 101:413-424.
234. Plotnikov A.N., Eliseenkova A.V., Ibrahimi O.A., et al. Crystal structure of fibroblast growth factor 9 reveals regions implicated in dimerization and autoinhibition. J. Biol. Chem. 2001, 276:4322-4329.
235. Poole T.J., Finkelstein E.B., Cox C.M. The role of FGF and VEGF in angioblast induction and migration during vascular development. Dev. Dyn. 2001, 220:1-17.
236. Powell P.P., Klagsbrun M. Three forms of rat basic fibroblast growth factor are made from a single mRNA and localize to the nucleus. J. Cell Physiol. 1991, 148:202-210.
237. Powers C.J., McLeskey S.W., Wellstein A. Fibroblast growth factors, their receptors and signaling. Endocr. Relat. Cancer 2000, 7:165-197.
238. Prats H., Kaghad M., Prats A.C., et al. High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons. Proc. Natl Acad. Sci. USA 1989, 86:1836-1840.
239. Presta M., Moscatelli D., Joseph-Silverstein J., Rifkin D.B. Purification from a human hepatoma cell line of a basic fibroblast growth factor-like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis, and migration. Mol. Cell Biol. 1986, 6:4060-4066.
240. Prudovsky I., Savion N., Zhan X., et al. Intact and functional fibroblast growth factor (FGF) receptor-1 trafficks near the nucleus in response to FGF-1. J. Biol. Chem. 1994, 269:31720-31724.
241. Prudovsky I.A., Savion N., LaVallee T.M., Maciag T. The nuclear trafficking of extracellular fibroblast growth factor (FGF)-1 correlates with the perinuclear association of the FGF receptor-1alpha isoforms but not the FGF receptor-1beta isoforms. J. Biol. Chem. 1996, 271:14198-14205.
242. Quito F.L., Beh J., Bashayan O., et al. Effects of fibroblast growth factor-4 (k-FGF) on long-term cultures of human bone marrow cells. Blood 1996, 87:1282-1291.
243. Raguenez G., Desire L., Lantrua V., Courtois Y. BCL-2 is upregulated in human SH-SY5Y neuroblastoma cells differentiated by overexpression of fibroblast growth factor 1. Biochem. Biophys. Res. Commun. 1999, 258:745-751.
244. Rapraeger A.C., Krufka A., Olwin B.B. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 1991, 252:1705-1708.
245. Ray J.M., Stetler-Stevenson W.G. Gelatinase A activity directly modulates melanoma cell adhesion and spreading. EMBO J. 1995, 14:908-917.
246. Reiland J., Rapraeger A.C. Heparan sulfate proteoglycan and FGF receptor target basic FGF to different intracellular destinations. J. Cell Sci. 1993, 105:1085-1093.
247. Reilly J.F., Maher P.A. Importin beta-mediated nuclear import of fibroblast growth factor receptor: role in cell proliferation. J. Cell Biol. 2001, 152:1307-1312.
248. Reimers K., Antoine M., Zapatka M., et al. NoBP, a nuclear fibroblast growth factor 3 binding protein, is cell cycle regulated and promotes cell growth. Mol. Cell Biol. 2001, 21:4996-5007.
249. Renier D., El Ghouzzi V., Bonaventure J., et al. Fibroblast growth factor receptor 3 mutation in nonsyndromic coronal synostosis: clinical spectrum, prevalence, and surgical outcome. J. Neurosurg. 2000, 92:631-636.
250. Renko M., Quarto N., Morimoto T., Rifkin D.B. Nuclear and cytoplasmic localization of different basic fibroblast growth factor species. J. Cell Physiol. 1990, 144:108-114.
251. Revest J.M., DeMoerlooze L., Dickson C. Fibroblast growth factor 9 secretion is mediated by a noncleaved amino-terminal signal sequence. J. Biol. Chem. 2000, 275:8083-8090.
252. Risau W., Flamme I. Vasculogenesis. Annu. Rev. Cell Dev. Biol. 1995, 11:73-91.
253. Roberts R., Gallagher J., Spooncer E., et al. Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis. Nature 1988, 332:376-378.
254. Roghani M., Moscatelli D. Basic fibroblast growth factor is internalized through both receptor mediated and heparan sulfate-mediated mechanisms. J. Biol. Chem. 1992, 267:22156-22162.
255. Rubin J.S., Osada H., Finch P.W., et al. Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc. Natl. Acad. Sci. USA 1989, 86:802-806.
256. Rusnati M., Presta M. Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans. Biological implications in neovascularization. Int. J. Clin. Lab Res. 1996, 26:15-23.
257. Rusnati M., Urbinati C., Presta M. Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: role of the low affinity heparin-like bFGF receptors. J. Cell Physiol. 1993, 154:152-161.
258. Rutter J.L., Benbow U., Coon C.I., Brinckerhoff C.E. Cell-type specific regulation of human interstitial collagenase-1 gene expression by interleukin-1 beta (IL-1 beta) in human fibroblasts and BC-8701 breast cancer cells. J. Cell Biochem. 1997, 66:322-336.
259. Samaniego F., Markham P.D., Gallo R.C., Ensoli B. Inflammatory cytokines induce AIDS-Kaposi’s sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi’s sarcoma-like lesion formation in nude mice. J. Immunol. 1995, 154:3582-3592.
260. Samaniego F., Markham P.D., Gendelman R., et al. Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi’s sarcoma-like lesions in nude mice. J. Immunol. 1997, 158:1887-1894.
261. Samaniego F., Markham P.D., Gendelman R., et al. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi’s sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development. Am. J. Pathol. 1998, 152:1433-1443.
262. Schweigerer L., Neufeld G., Friedman J., et al. Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature 1987, 325:257-259.
263. Segev A., Aviezer D., Safran M., et al. Inhibition of vascular smooth muscle cell proliferation by a novel fibroblast growth factor receptor antagonist. Cardiovasc. Res. 2002, 53:232-241.
264. Sekine K., Ohuchi H., Fujiwara M., et al. Fgf10 is essential for limb and lung formation. Nat. Genet. 1999, 21:138-141.
265. Sepp N.T., Li L.J., Lee K.H., et al. Basic fibroblast growth factor increases expression of the alpha v beta 3 integrin complex on human microvascular endothelial cells. J. Invest Dermatol. 1994, 103:295-299.
266. Sgadari C., Barillari G., Toschi E., et al. HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma. Nat. Med. 2002, 8:225-232.
267. Sharma B., Iozzo R.V. Transcriptional silencing of perlecan gene expression by interferon-gamma. J. Biol. Chem. 1998, 273:4642-4646.
268. Shi J., Friedman S., Maciag T. A carboxylterminal domain in fibroblast growth factor (FGF)-2 inhibits FGF-1 release in response to heat shock in vitro. J. Biol. Chem. 1997, 272:1142-1147.
269. Shing Y., Folkman J., Sullivan R., et al. Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science 1984, 223:1296-1299.
270. Shinya M., Koshida S., Sawada A., et al. Fgf signalling through MAPK cascade is required for development of the subpallial telencephalon in zebrafish embryos. Development 2001, 128:4153-4164.
271. Singh R.K., Gutman M., Bucana C.D., et al. Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas. Proc. Natl Acad. Sci. USA 1995, 92:4562-4566.
272. Slaton J.W., Inoue K., Perrotte P., et al. Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma. Am. J. Pathol. 2001, 158:735-743.
273. Smallwood P.M., Munoz-Sanjuan I., Tong P., et al. Fibroblast growth factor (FGF) homologous factors: new members of the FGF family implicated in nervous system development. Proc. Natl Acad. Sci. USA 1996, 93:9850-9857.
274. Sohal J., Chase A., Mould S., et al. Identification of four new translocations involving FGFR1 in myeloid disorders. Genes Chromosomes Cancer 2001, 32:155-163.
275. Stachowiak E.K., Maher P.A., Tucholski J., et al. Nuclear accumulation of fibroblast growth factor receptors in human glial cells-association with cell proliferation. Oncogene 1997, 14:2201-2211.
276. Stauber D.J., DiGabriele A.D., Hendrickson W.A. Structural interactions of fibroblast growth factor receptor with its ligands. Proc. Natl Acad. Sci. USA 2000, 97:49-54.
277. Steegmaier M., Borges E., Berger J., et al. The E-selectin-ligand ESL-1 is located in the Golgi as well as on microvilli on the cell surface. J. Cell Sci. 1997, 110:687-694.
278. Stephens T.D. Proposed mechanisms of action in thalidomide embryopathy. Teratology 1988, 38:229-239.
279. Stromblad S., Becker J.C., Yebra M., et al. Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis. J. Clin. Invest. 1996, 98:426-433.
280. Strutz F., Zeisberg M., Renziehausen A., et al. TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2). Kidney Int. 2001, 59:579-592.
281. Sturzl M., Zietz C., Monini P., Ensoli B. Human herpesvirus-8 and Kaposi’s sarcoma: relationship with the multistep concept of tumorigenesis. Adv. Cancer Res. 2001, 81:125-159.
282. Sun X., Meyers E.N., Lewandoski M., Martin G.R. Targeted disruption of Fgf8 causes failure of cell migration in the gastrulating mouse embryo. Genes Dev. 1999, 13:1834-1846.
283. Takahashi J.A., Mori H., Fukumoto M., et al. Gene expression of fibroblast growth factors in human gliomas and meningiomas: demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissues. Proc. Natl Acad. Sci. USA 1990, 87:5710-5714.
284. Takahashi J.A., Fukumoto M., Igarashi K., et al. Correlation of basic fibroblast growth factor expression levels with the degree of malignancy and vascularity in human gliomas. J. Neurosurg. 1992, 76:792-798.
285. Takahashi K., Mulliken J.B., Kozakewich H.P., et al. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J. Clin. Invest 1994, 93:2357-2364.
286. Tarantini F., Gamble S., Jackson A., Maciag T. The cysteine residue responsible for the release of fibroblast growth factor-1 residues in a domain independent of the domain for phosphatidylserine binding. J. Biol. Chem. 1995, 270:29039-29042.
287. Tarantini F., LaVallee T., Jackson A., et al. The extravesicular domain of synaptotagmin-1 is released with the latent fibroblast growth factor-1 homodimer in response to heat shock. J. Biol. Chem. 1998, 273:22209-22216.
288. Thomas K.A., Rios-Candelore M., Fitzpatrick S. Purification and characterization of acidic fibroblast growth factor from bovine brain. Proc. Natl Acad. Sci. USA 1984, 81:357-361.
289. Tooyama I., Kawamata T., Walker D., et al. Loss of basic fibroblast growth factor in substantia nigra neurons in Parkinson’s disease. Neurology 1993, 43:372-376.
290. Tooyama I., Kremer H.P., Hayden M.R., et al. Acidic and basic fibroblast growth factor-like immunoreactivity in the striatum and midbrain in Huntington’s disease. Brain Res. 1993, 610:1-7.
291. Toschi E., Barillari G., Sgadari C., et al. Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor. Mol. Biol. Cell 2001, 12:2934-2946.
292. Trudel C., Faure-Desire V., Florkiewicz R.Z., Baird A. Translocation of FGF2 to the cell surface without release into conditioned media. J. Cell Physiol. 2000, 185:260-268.
293. Tsuboi R., Sato Y., Rifkin D.B. Correlation of cell migration, cell invasion, receptor number, proteinase production, and basic fibroblast growth factor levels in endothelial cells. J. Cell Biol. 1990, 110:511-517.
294. Van den Berghe L., Laurell H., Huez I., et al. FIF [fibroblast growth factor-2 (FGF-2)-interacting-factor], a nuclear putatively antiapoptotic factor, interacts specifically with FGF-2. Mol. Endocrinol. 2000, 14:1709-1724.
295. van Rhijn B.W., Lurkin I., Radvanyi F., et al. The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate. Cancer Res. 2001, 61:1265-1268.
296. Venkataraman G., Raman R., Sasisekharan V., Sasisekharan R. Molecular characteristics of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex. Proc. Natl Acad. Sci. USA 1999, 96:3658-3663.
297. Vlodavsky I., Friedmann Y., Elkin M., et al. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat. Med. 1999, 5:793-802.
298. Walicke P.A., Baird A. Neurotrophic effects of basic and acidic fibroblast growth factors are not mediated through glial cells. Brain Res. 1988, 468:71-79.
299. Walicke P., Cowan W.M., Ueno N., et al. Fibroblast growth factor promotes survival of dissociated hippocampal neurons and enhances neurite extension. Proc. Natl Acad. Sci. USA 1986, 83:3012-3016.
300. Wang F., Kan M., McKeehan K., et al. A homeo-interaction sequence in the ectodomain of the fibroblast growth factor receptor. J. Biol. Chem. 1997, 272:23887-23895.
301. Wang F., Kan M., Yan G., et al. Alternately spliced NH2-terminal immunoglobulin-like Loop I in the ectodomain of the fibroblast growth factor (FGF) receptor 1 lowers affinity for both heparin and FGF-1. J. Biol. Chem. 1995, 270:10231-10235.
302. Wang J.K., Xu H., Li H.C., Goldfarb M. Broadly expressed SNT-like proteins link FGF receptor stimulation to activators of Ras. Oncogene 1996, 13:721-729.
303. Wang Q., McEwen D.G., Ornitz D.M. Subcellular and developmental expression of alternatively spliced forms of fibroblast growth factor 14. Mech. Dev. 2000, 90:283-287.
304. Werb Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell 1997, 91:439-442.
305. Werner S., Roth W.K., Bates B., et al. Fibroblast growth factor 5 proto-oncogene is expressed in normal human fibroblasts and induced by serum growth factors. Oncogene 1991, 6:2137-2144.
306. Whitelock J.M., Murdoch A.D., Iozzo R.V., Underwood P.A. The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases. J. Biol. Chem. 1996, 271:10079-10086.
307. Wiedlocha A., Falnes P.O., Rapak A., et al. Stimulation of proliferation of a human osteosarcoma cell line by exogenous acidic fibroblast growth factor requires both activation of receptor tyrosine kinase and growth factor internalization. Mol. Cell Biol. 1996, 16:270-280.
308. Winkles J.A., Friesel R., Burgess W.H., et al. Human vascular smooth muscle cells both express and respond to heparin-binding growth factor I (endothelial cell growth factor). Proc. Natl Acad. Sci. USA 1987, 84:7124-7128.
309. Wu D.Q., Kan M.K., Sato G.H., et al. Characterization and molecular cloning of a putative binding protein for heparin-binding growth factors. J. Biol. Chem. 1991, 266:16778-16785.
310. Xia Y.P., Zhao Y., Marcus J., et al. Effects of keratinocyte growth factor-2 (KGF-2) on wound healing in an ischaemia-impaired rabbit ear model and on scar formation. J. Pathol. 1999, 188:431-438.
311. Yamaguchi F., Saya H., Bruner J.M., Morrison R.S. Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas. Proc. Natl Acad. Sci. USA 1994, 91:484-488.
312. Yamaguchi T.P., Harpal K., Henkemeyer M., Rossant J. fgfr-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation. Genes Dev. 1994, 8:3032-3044.
313. Yamashita T., Yoshioka M., Itoh N. Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain. Biochem. Biophys. Res. Commun. 2000, 277:494-498.
314. Yano K., Nakagawa N., Yasuda H., et al. Synovial cells from a patient with rheumatoid arthritis produce osteoclastogenesis inhibitory factor/ osteoprotegerin: reciprocal regulation of the production by inflammatory cytokines and basic fibroblast growth factor. J. Bone Miner. Metab. 2001, 19:365-372.
315. Yoneda J., Kuniyasu H., Crispens M.A., et al. Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice. J. Natl. Cancer Inst. 1998, 90:447-454.
316. Yoshida T., IShimaru K., Sakamoto H., et al. Angiogenic activity of the recombinant hst-1 protein. Cancer Lett. 1994, 83:261-268.
317. Yu J.C., Lucas J.H., Fryberg K., Borke J.L. Extrinsic tension results in FGF-2 release, membrane permeability change, and intracellular Ca++ increase in immature cranial sutures. J. Craniofac. Surg. 2001, 12:391-398.
318. Yu W.H., Woessner J.F. Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7). J. Biol. Chem. 2000, 275:4183-4191.
319. Zhan X., Hu X., Friedman S., Maciag T. Analysis of endogenous and exogenous nuclear translocation of fibroblast growth factor-1 in NIH 3T3 cells. Biochem. Biophys. Res. Commun. 1992, 188:982-991.
320. Zhang J.D., Cousens L.S., Barr P.J., Sprang S.R. Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1 beta. Proc. Natl Acad. Sci. USA 1991, 88:3446-3450.
321. Zhang Z., Coomans C., David G. Membrane heparan sulfate proteoglycan-supported FGF2-FGFR1 signaling: evidence in support of the ’cooperative end structures’ model. J. Biol. Chem. 2001, 276:41921-41929.
322. Zhou Z., Zuber M.E., Burrus L.W., Olwin B.B. Identification and characterization of a fibroblast growth factor (FGF) binding domain in the cysteine-rich FGF receptor. J. Biol. Chem. 1997, 272:5167-5174.
323. Zuber M.E., Zhou Z., Burrus L.W., Olwin B.B. Cysteine-rich FGF receptor regulates intracellular FGF-1 and FGF-2 levels. J. Cell Physiol 1997, 170:217-227.